The Control of Hyperglycemia in Alloxan Treated Diabetic Mice through the Stimulation of Hepatic Insulin Synthesis due to the Production of Nitric Oxide

Abstract

Objective:

The hepatocytes from the adult mice when stimulated by glucose had been reported to synthesize and secrete insulin. The feasibility of controlling hyperglycemia in alloxan induced diabetic mice through hepatic synthesis of insulin was studied.

Materials and methods:

Insulin synthesis was determined by in vitro translation of mRNA and by immunohistochemistry of the hepatocytes and assayed by enzyme linked immunosorbent assay (ELISA). Dermcidin isoform 2 (dermcidin) was measured by ELISA. Nitric oxide was measured by methemoglobin method. Insulin synthesis was quantitated by immunoblot technique and the expression of proinsulin genes I and II in the hepatocytes was quantitated by cDNA synthesis

Results:

It was found that in contrast to normal hepatocytes, the hepatocytes from the diabetic mice showed impaired insulin synthesis in the presence of glucose that was related to the inhibition of nitric oxide synthesis through the synthesis of dermcidin, a potent competitive inhibitor of nitric oxide synthase. The increase of systemic NO synthesis either by oral use of 0.7 mM acetyl salicylic acid (aspirin) or by dermal application of 0.28 mmol sodium nitroprusside in saline soaked in cotton pad was found to decrease blood glucose level from 600 mg/dL to 120 mg/dL with concomitant increase of plasma insulin level from 5 µunits/dL to 38 µunits/dL. And subsequently normalized dermcidin level from 80 nM to 4.5 nM within 24 h (p<0.001; n=10).

Conclusion:

Our studies suggested the possibility of controlling hyperglycemia in alloxan induced diabetic mice by the stimulation of the hepatic insulin synthesis through the systemic stimulation of NO production in the hepatocytes.

Key words

insulin - hyperglycemia - dermcidin isoform 2 - acetyl salicylic acid - nitric oxide

• References

• 1 Baelde HJ, Cleton-Jansen AM, van Beerendonk H et al. High quality RNA isolation from tumors with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma. J Clin Pathol 2001; 54: 778-782
• 2 Chakraborty K, Khan GA, Banerjee P et al. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin. Platelets 2003; 14: 421-427
• 3 Chakraborty K, Sinha AK. The role of insulin as an antithrombotic humoral factor. Bioessays 2004; 26 (01) 91-98
• 4 Conrad EA, Bass AD. The influence of alloxan and dietary restriction on rat liver desoxyribonucleic acid (DNA). J Histochem Cytochem 1957; 5 (02) 182-187
• 5 Cox RD, Frank CW. Determination of nitrate and nitrite in blood and urine by Chemiluminiscence. J Anal Toxicol 1982; 6: 148-152
• 6 Ghosh R, Karmohapatra SK, Bhattacharya G et al. The glucose-induced synthesis of insulin in liver. Endocrine 2010; 38 (02) 294-302
• 7 Ghosh R, Karmohapatra SK, Bhattacharyya M et al. The appearance of dermcidin isoform 2, a novel platelet aggregating agent in the circulation in acute myocardial infarction that inhibits insulin synthesis and the restoration by acetyl salicylic acid of its effects. J Thromb Thrombolysis 2011; 31 (01) 13-21
• 8 Ghosh R, Maji UK, Bhattacharya R et al. The role of dermcidin isoform 2, a two faceted atherosclerotic risk factor for coronary artery disease and the effect of acetyl salicylic acid on it. Thrombosis 2011; (in press)
• 9 Guillam MT, Burcelin R, Thorens B. Normal hepatic glucose production in the absence of GLUT2 reveals an alternative pathway for glucose release from hepatocytes. Proc Natl Acad Sci USA 1998; 95 (21) 12317-12321
• 10 Hughes SD, Johnson JH, Quaade C et al. Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells. Proc Natl Acad Sci USA 1992; 15; 89 (02) 688-692
• 11 Jia L, Bonaventura C, Bonaventura J et al. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996; 380: 221-226
• 12 Kojima H, Fujimiya M, Matsumura K et al. Extrapancreatic insulin-producing cells in multiple organs in diabetes. Proc Natl Acad Sci USA 2004; 101 (08) 2458-2463
• 13 Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008; 51 (02) 216-226
• 14 Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem 1987; 262: 10035-10038
• 15 Sakuma I, Stuehr DJ, Gross SS et al. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85: 8664-8667
• 16 Sinha AK, Acharya K, Bhattacharya S et al. Neutralization by “antineoplastin” of insulin-activated nitric oxide synthase antibody and its effects in cancers. J Cancer Res Clin Oncol 2002; 128 (12) 659-668
• 17 Sinha AK, Bhattacharya S, Acharya K et al. Stimulation of nitric oxide synthesis and protective role of insulin in acute thrombosis in vivo. Life Sci 1999; 65 (25) 2687-2696
• 18 Zhang R, Zhou J, Jia Z et al. Hypoglycemic effect of Rehmannia glutinosa oligosaccharide in hyperglycemic and alloxan-induced diabetic rats and its mechanism. J Ethnopharmacol 2004; 90: 39-43
• 19 Zimmerman R, Paluch U, Sprinzl M et al. Cell-free synthesis of the mitochondrial ADP/ATP carrier protein of Neurospora crassa . Eur J Biochem 1979; 99: 247-252